Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase NA 11Phase 1 7Phase EARLY_PHASE1 2Phase 1/2 2Phase 4 1Phase 3 1Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Glioblastoma 276Brain Neoplasms 169Glioma 139Central Nervous System Neoplasms 85Gliosarcoma 79Astrocytoma 74Neuroblastoma 64Oligodendroglioma 42Neoplasms 40Breast Neoplasms 38Recurrence 37Carcinoma, Non-Small-Cell Lung 31Medulloblastoma 27Melanoma 26Ovarian Neoplasms 24Lymphoma 21Diffuse Intrinsic Pontine Glioma 21Sarcoma 19Neoplasm Metastasis 19Lung Neoplasms 18Colorectal Neoplasms 17Rhabdomyosarcoma 16Osteosarcoma 16Meningeal Carcinomatosis 15Ependymoma 15Pancreatic Neoplasms 14Meningioma 14Sarcoma, Ewing 13Stomach Neoplasms 12Esophageal Neoplasms 12

Interventions

Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Neurofibromatoses × CNS × Clear all
NCT05011019 2024-03-21

A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Terminated
22 enrolled
CNSSarcoma

Neurofibromatoses, Neurofibrosarcoma

NCT01140360 2017-07-02

0908-09

Indiana University

Phase 1/2 Completed
21 enrolled 8 charts
CNS

Neurofibroma, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡